{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T18:03:04Z","timestamp":1785866584382,"version":"3.56.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI124006"],"award-info":[{"award-number":["R01AI124006"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R43DK113858"],"award-info":[{"award-number":["R43DK113858"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004829","name":"Connecticut Innovations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004829","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.isci.2019.10.040","type":"journal-article","created":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T12:28:28Z","timestamp":1571920108000},"page":"391-402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Virus-like Vesicles Expressing Multiple Antigens for Immunotherapy of Chronic Hepatitis B"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0531-2559","authenticated-orcid":false,"given":"Timur O.","family":"Yarovinsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen W.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie M.","family":"Krady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Haslip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhaskara R.","family":"Madina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianyong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safiehkhatoon","family":"Moshkani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Chiale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anasuya Chattopadhyay","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijan","family":"Almassian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John K.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Robek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerian","family":"Nakaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2019.10.040_bib1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.antiviral.2012.07.011","article-title":"Strong and multi-antigen specific immunity by hepatitis B core antigen (HBcAg)-based vaccines in a murine model of chronic hepatitis B: HBcAg is a candidate for a therapeutic vaccine against hepatitis B virus","volume":"96","author":"Akbar","year":"2012","journal-title":"Antiviral Res."},{"key":"10.1016\/j.isci.2019.10.040_bib2","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.vaccine.2015.12.060","article-title":"Protein-prime\/modified vaccinia virus Ankara vector-boost vaccination overcomes tolerance in high-antigenemic HBV-transgenic mice","volume":"34","author":"Backes","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.isci.2019.10.040_bib3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.antiviral.2017.12.006","article-title":"Research priorities for the discovery of a cure for chronic hepatitis B: report of a workshop","volume":"150","author":"Block","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.isci.2019.10.040_bib4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/jvh.12649","article-title":"Protective efficacy and hepatitis B virus clearance in mice enhanced by cell-mediated immunity with novel prime-boost regimens","volume":"24","author":"Chuai","year":"2017","journal-title":"J.\u00a0Viral Hepat."},{"key":"10.1016\/j.isci.2019.10.040_bib5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/14712598.2017.1265940","article-title":"Present and future DNA vaccines for chronic hepatitis B treatment","volume":"17","author":"Cova","year":"2017","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.isci.2019.10.040_bib6","doi-asserted-by":"crossref","first-page":"5554","DOI":"10.1128\/JVI.03134-12","article-title":"Adeno-associated virus-mediated gene transfer leads to persistent hepatitis B virus replication in mice expressing HLA-A2 and HLA-DR1 molecules","volume":"87","author":"Dion","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.isci.2019.10.040_bib7","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra031087","article-title":"Hepatitis B virus infection \u2014 natural history and clinical consequences","volume":"350","author":"Ganem","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.isci.2019.10.040_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1074-7613(00)80295-2","article-title":"Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes","volume":"4","author":"Guidotti","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2019.10.040_bib9","doi-asserted-by":"crossref","first-page":"17862","DOI":"10.1073\/pnas.0608578103","article-title":"An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection","volume":"103","author":"Huang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.isci.2019.10.040_bib10","first-page":"301","article-title":"Hepatitis B virus: DNA polymerase activity of deletion mutants","volume":"47","author":"Kim","year":"1999","journal-title":"Biochem. Mol. Biol. Int."},{"key":"10.1016\/j.isci.2019.10.040_bib11","doi-asserted-by":"crossref","first-page":"e101904","DOI":"10.1371\/journal.pone.0101904","article-title":"A whole recombinant yeast-based therapeutic vaccine elicits HBV X, S and Core specific T\u00a0cells in mice and activates human T\u00a0cells recognizing epitopes linked to viral clearance","volume":"9","author":"King","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2019.10.040_bib12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.coviro.2017.03.011","article-title":"Therapeutic vaccination for chronic hepatitis B","volume":"23","author":"Kosinska","year":"2017","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.isci.2019.10.040_bib13","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1128\/JVI.73.3.1885-1893.1999","article-title":"Mapping of the hepatitis B virus reverse transcriptase TP and RT domains by transcomplementation for nucleotide priming and by protein-protein interaction","volume":"73","author":"Lanford","year":"1999","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.isci.2019.10.040_bib14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s12250-014-3410-5","article-title":"New therapeutic vaccination strategies for the treatment of chronic hepatitis B","volume":"29","author":"Liu","year":"2014","journal-title":"Virol. Sin."},{"key":"10.1016\/j.isci.2019.10.040_bib15","article-title":"Systematic comparison of 2A peptides for cloning multi-genes in a polycistronic vector","volume":"7","author":"Liu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2019.10.040_bib16","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1136\/gutjnl-2014-308041","article-title":"TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T\u00a0cells and exerts an antiviral effect in HBV-persistent mice","volume":"64","author":"Martin","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.isci.2019.10.040_bib17","doi-asserted-by":"crossref","first-page":"5863","DOI":"10.4049\/jimmunol.173.9.5863","article-title":"Cellular immune responses to the hepatitis B virus polymerase","volume":"173","author":"Mizukoshi","year":"2004","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.isci.2019.10.040_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01586-18","article-title":"A highly attenuated vesicular stomatitis virus-based vaccine platform controls hepatitis B virus replication in mouse models of hepatitis B","volume":"93","author":"Moshkani","year":"2019","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.isci.2019.10.040_bib19","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/0022-2836(92)90101-O","article-title":"Topological analysis of the hepatitis B virus core particle by cysteine-cysteine cross-linking","volume":"225","author":"Nassal","year":"1992","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.isci.2019.10.040_bib20","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/cgt.2013.65","article-title":"DNA vaccine cocktail expressing genotype A and C HBV surface and consensus core antigens generates robust cytotoxic and antibody responses in mice and Rhesus macaques","volume":"20","author":"Obeng-Adjei","year":"2013","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.isci.2019.10.040_bib21","doi-asserted-by":"crossref","first-page":"10407","DOI":"10.1128\/JVI.01184-15","article-title":"Virus-like vesicle-based therapeutic vaccine vectors for chronic hepatitis B virus infection","volume":"89","author":"Reynolds","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.isci.2019.10.040_bib22","doi-asserted-by":"crossref","first-page":"16866","DOI":"10.1073\/pnas.1414991111","article-title":"In\u00a0vitro evolution of high-titer, virus-like vesicles containing a single structural protein","volume":"111","author":"Rose","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.isci.2019.10.040_bib23","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.1073\/pnas.0800280105","article-title":"Hybrid alphavirus-rhabdovirus propagating replicon particles are versatile and potent vaccine vectors","volume":"105","author":"Rose","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.isci.2019.10.040_bib24","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.1128\/JVI.00342-11","article-title":"Significant protection against high-dose simian immunodeficiency virus challenge conferred by a new prime-boost vaccine regimen","volume":"85","author":"Schell","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.isci.2019.10.040_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6701a1","article-title":"Prevention of hepatitis B virus infection in the United States: recommendations of the advisory committee on immunization practices","volume":"67","author":"Schillie","year":"2018","journal-title":"MMWR Recomm. Rep."},{"key":"10.1016\/j.isci.2019.10.040_bib26","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/liv.13656","article-title":"Towards HBV curative therapies","volume":"38","author":"Schinazi","year":"2018","journal-title":"Liver Int."},{"key":"10.1016\/j.isci.2019.10.040_bib27","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.virol.2015.02.031","article-title":"Molecular biology of hepatitis B virus infection","volume":"479\u2013480","author":"Seeger","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.isci.2019.10.040_bib28","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.4049\/jimmunol.166.2.1389","article-title":"Overcoming T\u00a0cell tolerance to the hepatitis B virus surface antigen in hepatitis B virus-transgenic mice","volume":"166","author":"Sette","year":"2001","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.isci.2019.10.040_bib29","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1001\/jama.2018.3795","article-title":"Chronic hepatitis B infection","volume":"319","author":"Tang","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.isci.2019.10.040_bib30","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tim.2017.07.006","article-title":"Mechanisms of hepatitis B virus persistence","volume":"26","author":"Tsai","year":"2018","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.isci.2019.10.040_bib31","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02154-16","article-title":"Chikungunya, influenza, nipah, and Semliki forest chimeric viruses with vesicular stomatitis virus: actions in the brain","volume":"91","author":"van den Pol","year":"2017","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.isci.2019.10.040_bib32","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1128\/JVI.78.11.5707-5719.2004","article-title":"Longitudinal analysis of CD8+ T\u00a0cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy","volume":"78","author":"Webster","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.isci.2019.10.040_bib33","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.3892\/mmr.2015.3834","article-title":"Vaccination with ubiquitin-hepatitis B core antigen-cytoplasmic transduction peptide enhances the hepatitis B virus-specific cytotoxic T-lymphocyte immune response and inhibits hepatitis B virus replication in transgenic mice","volume":"12","author":"Zhuo","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.isci.2019.10.040_bib34","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1128\/JVI.73.5.4188-4196.1999","article-title":"Properties of monoclonal antibodies directed against hepatitis B virus polymerase protein","volume":"73","author":"zu Putlitz","year":"1999","journal-title":"J.\u00a0Virol."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004219304201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004219304201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T17:00:55Z","timestamp":1785862855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004219304201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":34,"alternative-id":["S2589004219304201"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2019.10.040","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/491985","asserted-by":"object"}]},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Virus-like Vesicles Expressing Multiple Antigens for Immunotherapy of Chronic Hepatitis B","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2019.10.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors.","name":"copyright","label":"Copyright"}]}}